← Open Payments lookup

ABRIANA GAUL: Open Payments

NPI 1821647884 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$347 in 17 payments from 8 companies in 2025. Trend: 2023 $436 · 2024 $214 · 2025 $347

Food & beverage: $347
CompanyPaymentsAmount
GENZYME CORPORATION4$109
Amgen Inc.4$67
Novartis Pharmaceuticals Corporation2$45
ACADIA Pharmaceuticals Inc2$39
Biogen, Inc.2$32
CSL Behring1$22
Chiesi USA, Inc.1$17
Grifols USA, LLC1$15

Products named: FABRAZYME, Repatha, LEQVIO, NUPLAZID, TYSABRI, Hizentra, CLEVIPREX, Gamunex-C.

Industry payments across TX — which companies pay providers there.